3
Announcements
Trials
Browse
Landscape
Phase
Phase NA
1
Status
Completed
22
Unknown
4
Withdrawn
1
Terminated
1
Recruiting
1
Active not recruiting
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Genitourinary
1
Conditions
Small Cell Lung Carcinoma
27
Lymphoma, Large B-Cell, Diffuse
10
Lung Neoplasms
8
Precursor Cell Lymphoblastic Leukemia-Lymphoma
6
Lymphoma, Non-Hodgkin
6
Lymphoma, B-Cell
6
Hodgkin Disease
6
Burkitt Lymphoma
6
Neuroblastoma
5
Medulloblastoma
5
Neoplasms, Germ Cell and Embryonal
4
Leukemia, Myeloid, Acute
4
Small Cell Lung Cancer Extensive Stage
3
Seminoma
3
Retinoblastoma
3
Recurrence
3
Ovarian Neoplasms
3
Multiple Myeloma
3
Lymphoma
3
Carcinoma, Neuroendocrine
3
Brain Neoplasms
3
Wilms Tumor
2
Urinary Bladder Neoplasms
2
Teratoma
2
Sarcoma, Ewing
2
Precursor T-Cell Lymphoblastic Leukemia-Lymphoma
2
Plasmablastic Lymphoma
2
Neuroectodermal Tumors, Primitive
2
Lymphoma, T-Cell
2
Lymphoma, Mantle-Cell
2
Interventions
Platinum
2
Magnetic Resonance Spectroscopy
2
Blood Specimen Collection
2
trastuzumab deruxtecan
1
sodium thiosulfate
1
claudin 6
1
brodalumab
1
Ultrasonography
1
Surveys and Questionnaires
1
Neoadjuvant Therapy
1
Methods
1
Mesothelin
1
Hearing
1
Fluorodeoxyglucose F18
1
FAPI-46
1
Exercise
1
Etoposide
1
Cisplatin
1
Bleomycin
1
Aspirin
1
1,2-diaminocyclohexaneplatinum II citrate
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Recruiting
×
Testicular Neoplasms
×
Etoposide
×
Clear all
NCT07498959
2026-03-27
TESTIGO
Sahlgrenska University Hospital
Phase NA
Recruiting
160 enrolled